Published in J Infect Dis on May 31, 2005
Use of human tissue explants to study human infectious agents. Nat Protoc (2009) 1.52
An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci U S A (2006) 1.23
Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation. J Virol (2006) 1.04
Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection. Am J Reprod Immunol (2011) 1.00
Contrasting roles for TLR ligands in HIV-1 pathogenesis. PLoS One (2010) 0.97
Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication. PLoS One (2008) 0.93
Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo. J Virol (2007) 0.86
Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants. PLoS One (2010) 0.86
Coinfecting viruses as determinants of HIV disease. Curr HIV/AIDS Rep (2009) 0.86
HIV RNA suppression among HIV-infected Ugandan children with measles. J Acquir Immune Defic Syndr (2008) 0.85
Long-term changes of serum chemokine levels in vaccinated military personnel. BMC Immunol (2006) 0.81
Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia Virus. BMC Immunol (2010) 0.80
Suppression of human immunodeficiency virus type 1 viral load during acute measles. Pediatr Infect Dis J (2009) 0.80
Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults. Vaccine (2011) 0.79
Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi. PLoS One (2009) 0.77
Toxoplasma gondii inhibits R5 HIV-1 replication in human lymphoid tissues ex vivo. Microbes Infect (2009) 0.77
Histocultures (tissue explants) in human retrovirology. Methods Mol Biol (2014) 0.76
Immature CD4+CD8+ thymocytes are preferentially infected by measles virus in human thymic organ cultures. PLoS One (2012) 0.76
HIV-1 infection ex vivo accelerates measles virus infection by upregulating signaling lymphocytic activation molecule (SLAM) in CD4+ T cells. J Virol (2012) 0.75
Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis (2008) 4.80
A method of active case detection to target reservoirs of asymptomatic malaria and gametocyte carriers in a rural area in Southern Province, Zambia. Malar J (2010) 2.83
Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood (2007) 2.21
Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet (2005) 2.11
Do children infected with HIV receiving HAART need to be revaccinated? Lancet Infect Dis (2010) 1.94
The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis (2007) 1.89
HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature (2013) 1.84
Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect Dis (2008) 1.83
Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog (2009) 1.81
Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey. Lancet (2009) 1.71
Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis. BMC Infect Dis (2009) 1.58
A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. J Virol Methods (2006) 1.49
HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy. PLoS One (2011) 1.47
Selective transmission of R5 HIV-1 variants: where is the gatekeeper? J Transl Med (2011) 1.36
Feasibility of satellite image-based sampling for a health survey among urban townships of Lusaka, Zambia. Trop Med Int Health (2008) 1.35
Differences in presentation, treatment initiation, and response among children infected with human immunodeficiency virus in urban and rural Zambia. Pediatr Infect Dis J (2010) 1.34
Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue. J Virol (2004) 1.32
Reduced risk of malaria parasitemia following household screening and treatment: a cross-sectional and longitudinal cohort study. PLoS One (2012) 1.32
Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin Infect Dis (2008) 1.27
The changing burden of malaria and association with vector control interventions in Zambia using district-level surveillance data, 2006-2011. Malar J (2013) 1.25
Changes in the burden of malaria following scale up of malaria control interventions in Mutasa District, Zimbabwe. Malar J (2013) 1.24
Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis. J Clin Microbiol (2009) 1.23
Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study. BMC Infect Dis (2011) 1.21
Measles vaccines. Front Biosci (2008) 1.19
HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo. Blood (2007) 1.19
CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors. J Virol (2011) 1.19
HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection. J Infect Dis (2009) 1.17
Management and outcomes of intracranial tuberculomas developing during antituberculous therapy: case report and review. Clin Pediatr (Phila) (2005) 1.14
Malaria research challenges in low prevalence settings. Malar J (2012) 1.14
Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya. Malar J (2010) 1.10
Risk factors for pre-treatment mortality among HIV-infected children in rural Zambia: a cohort study. PLoS One (2011) 1.09
Efficiency of household reactive case detection for malaria in rural Southern Zambia: simulations based on cross-sectional surveys from two epidemiological settings. PLoS One (2013) 1.05
High burden of malaria following scale-up of control interventions in Nchelenge District, Luapula Province, Zambia. Malar J (2014) 1.04
Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation. J Virol (2006) 1.04
Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles. Clin Diagn Lab Immunol (2002) 1.04
Improved measles surveillance in Cameroon reveals two major dynamic patterns of incidence. Int J Infect Dis (2005) 1.04
Incidence of influenza virus infection in early infancy: a prospective study in South Asia. Pediatr Infect Dis J (2011) 1.03
Altered synthesis of interleukin-12 and type 1 and type 2 cytokinesin rhesus macaques during measles and atypical measles. J Infect Dis (2001) 1.00
Activation of T lymphocytes in atherosclerotic plaques. Arterioscler Thromb Vasc Biol (2011) 1.00
In vitro suppression of human immunodeficiency virus type 1 replication by measles virus. J Virol (2005) 1.00
Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue. J Virol (2005) 0.99
Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model. Int J Epidemiol (2008) 0.99
Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study. BMC Pediatr (2010) 0.99
Correlates of sexual activity and sexually transmitted infections among human immunodeficiency virus-infected youth in the LEGACY cohort, United States, 2006. Pediatr Infect Dis J (2011) 0.98
The association of Blastocystis hominis and Endolimax nana with diarrheal stools in Zambian school-age children. Parasitol Res (2005) 0.98
Neonatal survival interventions in humanitarian emergencies: a survey of current practices and programs. Confl Health (2012) 0.97
Seasonal concentrations and determinants of indoor particulate matter in a low-income community in Dhaka, Bangladesh. Environ Res (2012) 0.97
Immunologic basis for revaccination of HIV-infected children receiving HAART. Future Virol (2011) 0.96
Streptomyces bikiniensis bacteremia. Emerg Infect Dis (2003) 0.95
Research priorities for global measles and rubella control and eradication. Vaccine (2012) 0.95
Slow clearance of measles virus RNA after acute infection. J Clin Virol (2007) 0.95
Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. J Infect Dis (2011) 0.94
Estimating the force of measles virus infection from hospitalised cases in Lusaka, Zambia. Vaccine (2004) 0.94
Incidence and risk factors for Malaria, pneumonia and diarrhea in children under 5 in UNHCR refugee camps: A retrospective study. Confl Health (2011) 0.94
Characterization of a lysosomal serine carboxypeptidase from Trypanosoma cruzi. Mol Biochem Parasitol (2003) 0.93
Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination. J Infect Dis (2007) 0.93
Changing individual-level risk factors for malaria with declining transmission in southern Zambia: a cross-sectional study. Malar J (2011) 0.93
Segregation of R5 and X4 HIV-1 variants to memory T cell subsets differentially expressing CD62L in ex vivo infected human lymphoid tissue. AIDS (2002) 0.92
Gene expression changes in peripheral blood mononuclear cells during measles virus infection. Clin Vaccine Immunol (2007) 0.92
Measles virus inhibits human immunodeficiency virus type 1 reverse transcription and replication by blocking cell-cycle progression of CD4+ T lymphocytes. J Gen Virol (2008) 0.91
Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities. J Infect Dis (2013) 0.90
Genotyping of measles virus in clinical specimens on the basis of oligonucleotide microarray hybridization patterns. J Clin Microbiol (2006) 0.89
Increased thymic output during acute measles virus infection. J Virol (2003) 0.88
The burden of malaria in post-emergency refugee sites: A retrospective study. Confl Health (2011) 0.87
CD4+ and CD8+ T-lymphocyte subsets in Zambian children. J Trop Pediatr (2004) 0.87
Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo. J Virol (2004) 0.87
Bystander CD4+ T lymphocytes survive in HIV-infected human lymphoid tissue. AIDS Res Hum Retroviruses (2003) 0.86
Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutations. J Virol (2007) 0.86
Depletion of CD4 T lymphocytes in human lymphoid tissue infected ex vivo with doxycycline-dependent HIV-1. Virology (2004) 0.85
Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A. Retrovirology (2009) 0.85
The urgent need for recommendations on revaccination of HIV-infected children after successful antiretroviral therapy. Clin Infect Dis (2010) 0.85
Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo. AIDS Res Hum Retroviruses (2008) 0.83
Differential effects of priming with DNA vaccines encoding the hemagglutinin and/or fusion proteins on cytokine responses after measles virus challenge. J Infect Dis (2003) 0.83
Indoor exposure to particulate matter and age at first acute lower respiratory infection in a low-income urban community in Bangladesh. Am J Epidemiol (2014) 0.83
Effectiveness of efavirenz-based regimens in young HIV-infected children treated for tuberculosis: a treatment option for resource-limited settings. PLoS One (2013) 0.83
Immunologic risk factors for early mortality after starting antiretroviral therapy in HIV-infected Zambian children. AIDS Res Hum Retroviruses (2012) 0.83
HIV-1 expressing the envelopes of transmitted/founder or control/reference viruses have similar infection patterns of CD4 T-cells in human cervical tissue ex vivo. PLoS One (2012) 0.82
HIV-1 infection as a risk factor for incomplete childhood immunization in Zambia. J Trop Pediatr (2006) 0.82
Antiretroviral therapy restores age-dependent loss of resting memory B cells in young HIV-infected Zambian children. J Acquir Immune Defic Syndr (2014) 0.81
Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART. J Acquir Immune Defic Syndr (2014) 0.81
Cochlear implant fixation using a subperiosteal tight pocket without either suture or bone-recess technique. Laryngoscope (2014) 0.80
Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study. BMC Public Health (2013) 0.79
Validation of oral fluid samples to monitor serological changes to Plasmodium falciparum: an observational study in southern Zambia. Malar J (2011) 0.79
Temporal and spatial patterns of serologic responses to Plasmodium falciparum antigens in a region of declining malaria transmission in southern Zambia. Malar J (2012) 0.79
Evaluating the impact of the HIV pandemic on measles control and elimination. Bull World Health Organ (2005) 0.79
False-positive HIV test results in infancy and management of uninfected children receiving antiretroviral therapy. Pediatr Infect Dis J (2015) 0.79
The effect of exclusive breast-feeding on respiratory illness in young infants in a maternal immunization trial in Bangladesh. Pediatr Infect Dis J (2013) 0.78
HIV integration and T cell death: additional commentary. Retrovirology (2013) 0.78
Individual- and Household-Level Risk Factors Associated with Malaria in Mutasa District, Zimbabwe: A Serial Cross-Sectional Study. Am J Trop Med Hyg (2016) 0.78
Emerging diseases: measles. J Neurovirol (2005) 0.77
Survey of human antibody responses to influenza virus matrix protein 2 by use of a sensitive flow cytometric method. J Infect Dis (2013) 0.77
Factors Associated with Sustained Use of Long-Lasting Insecticide-Treated Nets Following a Reduction in Malaria Transmission in Southern Zambia. Am J Trop Med Hyg (2015) 0.77
Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh. J Virol Methods (2013) 0.77
Cervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort. J Pediatr Adolesc Gynecol (2011) 0.77
Delays in Initiation of Antiretroviral Therapy Among HIV-infected Children in Rural Zambia. Pediatr Infect Dis J (2016) 0.77
Immature CD4+CD8+ thymocytes are preferentially infected by measles virus in human thymic organ cultures. PLoS One (2012) 0.76
Impact of Haemophilus influenzae Type B Conjugate Vaccines on Nasopharyngeal Carriage in HIV-infected Children and Their Parents From West Bengal, India. Pediatr Infect Dis J (2016) 0.76
The effects of maternal malaria and HIV-1 infection on the effort to eliminate neonatal tetanus. J Infect Dis (2007) 0.75
Measles and Rubella Seroprevalence Among HIV-Infected And Uninfected Zambian Youth. Pediatr Infect Dis J (2016) 0.75